Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00661583 · ClinicalTrials.gov registry record · Phase 1
Use of Ranibizumab With Mitomycin C During Trabeculectomy
A Phase 1 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00661583: Completed Phase 1 study, sponsored by University of Colorado, Denver.
NCT00661583 is a Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00661583, a Phase 1 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of the study is to study the safety of the combination of ranibizumab and MMC vs monotherapy MMC vs intravitreal ranibizumab injection in patients with glaucoma.
Primary Outcome
To assess ocular adverse events of combination ranibizumab and MMC therapy at 6 months
Interventions
- DRUG MMC
- DRUG Ranibizumab
- DRUG Ranibizumab and MMC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-04 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
What the finished NCT00661583 record still lists
NCT00661583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 3 interventions - of which MMC is the first listed.
NCT00661583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00661583 about?
NCT00661583 is a clinical study titled "Use of Ranibizumab With Mitomycin C During Trabeculectomy". The purpose of the study is to study the safety of the combination of ranibizumab and MMC vs monotherapy MMC vs intravitreal ranibizumab injection in patients with glaucoma.
What is the current status of trial NCT00661583?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2008-04. Estimated completion is 2014-09.
What interventions are being tested in trial NCT00661583?
The interventions under investigation include: MMC (DRUG), Ranibizumab (DRUG), Ranibizumab and MMC (DRUG).
Who is sponsoring clinical trial NCT00661583?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00661583's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia